Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
9741
ECA structural model diagram.
Published 2025“…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
-
9742
Heat maps for different models.
Published 2025“…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
-
9743
Defect category statistics.
Published 2025“…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
-
9744
CARAFE general structure.
Published 2025“…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
-
9745
lncRNA-GAS5 affects the cell cycle and apoptosis of HSVSMCs.
Published 2015“…<b>C:</b> The apoptosis of HSVSMCs were measured by Flow Cytometry using Annexin V-FITC apoptosis kit. The result shows that the HSVSMCs in early apoptosis decreased with overexpression of lncRNA-GAS5. …”
-
9746
-
9747
-
9748
-
9749
-
9750
-
9751
-
9752
Rescue of <i>MBNL</i>1 e5 and <i>MBNL</i>2 e5 and e8 mis-splicing by erythromycin lactobionate treatment at 10 DPI.
Published 2022“…Note the decreased inclusion of <i>MBNL</i>1 e5 (+e5) and <i>MBNL</i>2 e5 (+e5) in DM1 hiNeurons treated with 35 or 65 μM erythromycin for 48 h relative to placebo treated cells. …”
-
9753
-
9754
-
9755
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors
Published 2025“…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
-
9756
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors
Published 2025“…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
-
9757
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors
Published 2025“…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
-
9758
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors
Published 2025“…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
-
9759
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors
Published 2025“…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
-
9760